A detailed history of Atwater Malick LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Atwater Malick LLC holds 55,609 shares of DGX stock, worth $7.62 Million. This represents 2.46% of its overall portfolio holdings.

Number of Shares
55,609
Previous 54,939 1.22%
Holding current value
$7.62 Million
Previous $7.52 Million 1.37%
% of portfolio
2.46%
Previous 2.59%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$137.09 - $137.09 $91,850 - $91,850
670 Added 1.22%
55,609 $7.62 Million
Q2 2024

Jul 17, 2024

BUY
$125.91 - $144.34 $23,922 - $27,424
190 Added 0.35%
54,939 $7.52 Million
Q1 2024

Apr 16, 2024

BUY
$123.78 - $142.11 $96,424 - $110,703
779 Added 1.44%
54,749 $7.29 Million
Q4 2023

Jan 11, 2024

BUY
$120.62 - $141.12 $150,051 - $175,553
1,244 Added 2.36%
53,970 $7.44 Million
Q3 2023

Oct 17, 2023

BUY
$121.86 - $144.92 $77,259 - $91,879
634 Added 1.22%
52,726 $6.43 Million
Q2 2023

Jul 17, 2023

BUY
$130.56 - $146.84 $223,910 - $251,830
1,715 Added 3.4%
52,092 $7.32 Million
Q1 2023

Apr 19, 2023

BUY
$131.53 - $155.76 $96,543 - $114,327
734 Added 1.48%
50,377 $7.13 Million
Q4 2022

Feb 14, 2023

BUY
$123.31 - $157.26 $104,196 - $132,884
845 Added 1.73%
49,643 $7.76 Million
Q3 2022

Nov 02, 2022

BUY
$121.77 - $141.1 $153,917 - $178,350
1,264 Added 2.66%
48,798 $5.99 Million
Q2 2022

Jul 21, 2022

BUY
$127.07 - $145.39 $141,047 - $161,382
1,110 Added 2.39%
47,534 $6.32 Million
Q1 2022

Apr 08, 2022

BUY
$129.09 - $164.35 $302,328 - $384,907
2,342 Added 5.31%
46,424 $6.35 Million
Q4 2021

Jan 21, 2022

BUY
$140.36 - $173.01 $99,094 - $122,145
706 Added 1.63%
44,082 $7.63 Million
Q3 2021

Oct 14, 2021

BUY
$132.95 - $158.0 $129,892 - $154,366
977 Added 2.3%
43,376 $6.3 Million
Q2 2021

Jul 26, 2021

BUY
$126.66 - $141.48 $372,887 - $416,517
2,944 Added 7.46%
42,399 $5.6 Million
Q1 2021

May 21, 2021

SELL
$114.63 - $133.34 $238,545 - $277,480
-2,081 Reduced 5.01%
39,455 $5.06 Million
Q4 2020

Jan 20, 2021

BUY
$112.7 - $128.05 $44,516 - $50,579
395 Added 0.96%
41,536 $4.95 Million
Q3 2020

Oct 13, 2020

BUY
$107.05 - $130.01 $79,752 - $96,857
745 Added 1.84%
41,141 $4.71 Million
Q2 2020

Jul 23, 2020

BUY
$73.34 - $122.61 $134,285 - $224,498
1,831 Added 4.75%
40,396 $4.6 Million
Q1 2020

Apr 24, 2020

BUY
$75.14 - $115.68 $189,127 - $291,166
2,517 Added 6.98%
38,565 $3.1 Million
Q4 2019

Jan 07, 2020

BUY
$100.29 - $107.99 $140,305 - $151,078
1,399 Added 4.04%
36,048 $3.85 Million
Q3 2019

Oct 15, 2019

BUY
$97.85 - $107.42 $154,113 - $169,186
1,575 Added 4.76%
34,649 $3.71 Million
Q2 2019

Jul 11, 2019

BUY
$85.18 - $101.94 $76,150 - $91,134
894 Added 2.78%
33,074 $3.37 Million
Q1 2019

Apr 12, 2019

BUY
$80.68 - $89.92 $278,103 - $309,954
3,447 Added 12.0%
32,180 $2.89 Million
Q4 2018

Mar 21, 2019

BUY
$79.75 - $108.38 $2.29 Million - $3.11 Million
28,733 New
28,733 $2.39 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Atwater Malick LLC Portfolio

Follow Atwater Malick LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atwater Malick LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atwater Malick LLC with notifications on news.